Rosario Mazzola

Ospedale Sacro Cuore Don Calabria

Papers

1

Total Citations

45

H-Index

1

About

Rosario Mazzola is a leading figure in radiation oncology, with a focused expertise in the application of advanced radiotherapy techniques for prostate cancer. His major contributions center on the clinical implementation of moderate hypofractionation combined with volumetric modulated arc therapy and daily image guidance (VMAT-IGRT) for postprostatectomy patients. His seminal 2017 work, cited over 45 times, demonstrated the feasibility and favorable acute toxicity profile of this approach, establishing a critical evidence base for shorter, more convenient treatment regimens without compromising safety. By pioneering these protocols, Mazzola has directly influenced clinical guidelines and improved patient quality of life during curative treatment. His research bridges the gap between technological innovation and practical patient care, showcasing how precise dose delivery can reduce side effects while maintaining therapeutic efficacy. A prolific investigator, his work continues to shape modern radiotherapy paradigms, making him a respected voice in genitourinary oncology and a key contributor to the evolution of evidence-based, patient-centered radiation therapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
45
Total Citations
45
Avg Citations/Paper
🏆 Most Cited Paper
Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity
45 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Ospedale Sacro Cuore Don Calabria

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago